|
Independent research & practical ideas for global prosperity
|
|
|
|
Independent research & practical ideas for global prosperity
|
|
 Posts:February 2, 2010A Global Tour of Drug ResistanceBy Rachel NugentKatherine Douglas contributed to this post.
Comment »January 11, 2010The End of Exile for Sexual and Reproductive Health and RightsBy Rachel Nugent Courtesy U.S. State Department When it comes to Secretary of State Hillary Clinton, no sliver of the international development community is more enamored than the sexual and reproductive health and rights (SRHR) crowd (yes, that’s their self-designation). Last Friday, Hillary returned the love. In a speech (see the full text here) in the regal Benjamin Franklin reception room at the State Department, Secretary of State Clinton and many of her top staff brought the international dimension of reproductive health and family planning in from the cold. It’s been a long winter. Read More… Comment »December 28, 2009A Public Health Time BombBy Rachel NugentEmma Back and Alix Beith, consultants to the CGD Drug Resistance Working Group, contributed to this post. There’s a lot of attention being paid to the counterfeit drug trade at the moment. Former President of France, Jacques Chirac, recently chaired a meeting with West African leaders to discuss how to crack down on counterfeiting. Meanwhile, the Wellcome Trust and the American Pharmaceutical Group held an Opinion Formers’ conference on counterfeit medicines (presentations here); the International Federation of Pharmaceutical Manufacturers and Associations produced a brief on the issue; and Roger Bate has continued to draw attention to counterfeits and other drug quality issues in developing countries, including through his book Making a Killing. And this is all on top of the WHO-hosted IMPACT initiative on counterfeits, which started in 2006. 2 Comments »December 1, 2009Comment on Our Drug Resistance Consultation ReportBy Rachel NugentWe’ve brought up the topic of drug resistance many times on this blog because we think it’s an important issue that doesn’t get enough attention. Resistance plagues the ability to successfully treat diseases in both rich and poor countries and the problem continues to grow every day. More advanced drugs that treat resistant forms of diseases cost vastly more than first-line drugs, and the cure rate is lower. Experts in drug development and disease treatment are very concerned about this problem, but those concerns have not been taken up by those who make the big decisions on global health. It’s past time they were. Read More… Comment »November 13, 2009Health Systems 101By Rachel NugentAs we’ve commented upon many times in this blog, the exploding interest in health systems strengthening (HSS) has spread to many global institutions. The IHP+ and the High-Level Task Force on Innovative Financing for Health both aim to strengthen health systems through MDGs 4 and 5. The World Bank, the Global Fund and GAVI are creating a joint health systems strengthening platform, and WHO is ramping up its activities on HSS, particularly on health worker issues. Targeted interventions are being delivered through health systems programming, such as USAIDs Health Systems 20/20. Read More… 2 Comments »November 9, 2009A Low-Key Summit with High-Key PotentialBy Rachel Nugent
This is a joint post with Emma Back, consultant to the CGD Drug Resistance Working Group. Last week’s 2009 US-EU Summit was hosted in Washington by President Obama and, while it didn’t exactly hog newspaper headlines, it did yield a few surprises. Alongside the expected commitments to co-operation on issues such as climate change and global security, the two parties also agreed “to establish a transatlantic task force on urgent antimicrobial resistance issues.” Wow! Where did that come from? Read More… 2 Comments »October 1, 2009A New Center on Disease OutbreaksBy Rachel NugentResources for the Future is launching a new Center for Disease Dynamics, Economics, and Policy next week. The lunchtime launch is on Wednesday, October 7 and open to the public. The Center’s name may be long and a bit wonky, but the purpose is simple: conduct analysis to improve prediction and prevention of disease outbreak and spread – here in the U.S. and globally. That sounds a lot like the CDC, doesn’t it? Read More… Comment » |
|
|
CENTER FOR GLOBAL DEVELOPMENT
1800 Massachusetts Avenue NW, Third Floor
Washington DC 20036
Tel 202.416.4000 | Fax 202.416.4050
|
|
|
Print
Share
